Study #2023-0332
Melanoma patient reported outcomes after RT (MelPRO-RT): Evaluating late toxicity after hypofractionated adjuvant radiation therapy for locoregional melanoma
MD Anderson Study Status
Enrolling
Treatment Agent
Description
MelPRO-RT: Toxicity after hypofractionated adjuvant radiation therapy for locoregional melanoma
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Melanoma, Skin
Study phase:
Not applicable
Physician name:
Devarati Mitra
Department:
Radiation Oncology
For general questions about clinical trials:
1-855-479-2433
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.